Literature DB >> 10453370

Presenting symptoms and diagnostic lag in children with inflammatory bowel disease.

J B Heikenen1, S L Werlin, C W Brown, J P Balint.   

Abstract

Presenting symptoms and their duration may affect the time that elapses prior to definitive diagnosis of inflammatory bowel disease (IBD). This study was undertaken to determine the mean duration of presenting symptoms and diagnostic lag in children with IBD. The medical records of all patients less than 19 years of age diagnosed with IBD at the pediatric gastroenterology clinic of Children's Hospital of Wisconsin between 1990-1995 were reviewed. The age at diagnosis, gender, presenting symptoms and duration, disease location, and diagnostic lag were analyzed. There were 91 children (49 male) diagnosed with IBD. Crohn's disease (CD) was diagnosed in 58, ulcerative colitis (UC) in 24, and indeterminate colitis in 9. The mean ages at diagnosis were 11.4 years for CD, 9.7 years for UC, and 7.8 years for indeterminate colitis. The most frequent presenting symptoms were abdominal pain, diarrhea, hematochezia, and weight loss. The average lag in diagnosis of CD was 7.1 months, which varied by disease location: small intestine 10.5 months, ileocolonic 7.5 months, and colonic 6.4 months. The average lag in diagnosis was 6.7 months for UC and 14 months for indeterminate colitis. Children presenting with growth failure had the longest diagnostic lag. (a) The elapsed time between symptom onset and the diagnosis of CD has decreased. (b) The diagnostic lag in CD decreases with distal colonic involvement. (c) Following onset of symptoms UC was diagnosed only slightly more rapidly than CD.

Entities:  

Mesh:

Year:  1999        PMID: 10453370     DOI: 10.1097/00054725-199908000-00002

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  16 in total

1.  Impact of pain on health-related quality of life in patients with inflammatory bowel disease.

Authors:  Anja Schirbel; Anne Reichert; Stephanie Roll; Daniel C Baumgart; Carsten Büning; Bianca Wittig; Bertram Wiedenmann; Axel Dignass; Andreas Sturm
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

2.  Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.

Authors:  Krishna P Reddy; Jonathan E Markowitz; Eduardo D Ruchelli; Robert N Baldassano; Kurt A Brown
Journal:  Dig Dis Sci       Date:  2007-01-12       Impact factor: 3.199

3.  Evaluation of possible inflammatory bowel disease: a survey of Rhode Island physicians.

Authors:  Sumona Saha; Manuel Lam; Erica Roberson; Samir Shah; Neal S LeLeiko; Sheldon Lidofsky; Renee Bright; Nicole Flowers; Marjorie Merrick; Bruce E Sands
Journal:  Med Health R I       Date:  2012-01

4.  Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon.

Authors:  Adam M Zahm; Nicholas J Hand; Daphne M Tsoucas; Claire L Le Guen; Robert N Baldassano; Joshua R Friedman
Journal:  J Crohns Colitis       Date:  2014-03-07       Impact factor: 9.071

5.  Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17.

Authors:  Giulio Kleiner; Valentina Zanin; Lorenzo Monasta; Sergio Crovella; Lorenzo Caruso; Daniela Milani; Annalisa Marcuzzi
Journal:  Exp Ther Med       Date:  2015-03-19       Impact factor: 2.447

6.  The -237C-->T promoter polymorphism of the SLC11A1 gene is associated with a protective effect in relation to inflammatory bowel disease in the South African population.

Authors:  Monique G Zaahl; Trevor A Winter; Louise Warnich; Maritha J Kotze
Journal:  Int J Colorectal Dis       Date:  2005-07-30       Impact factor: 2.571

7.  Diagnostic Delay in Pediatric Inflammatory Bowel Disease: A Systematic Review.

Authors:  Aymane Ajbar; Eleanor Cross; Simbarashe Matoi; Charles A Hay; Libby M Baines; Benjamin Saunders; Adam D Farmer; James A Prior
Journal:  Dig Dis Sci       Date:  2022-03-14       Impact factor: 3.199

8.  Evaluation of Gastrointestinal Patient Reported Outcomes Measurement Information System (GI-PROMIS) Symptom Scales in Subjects With Inflammatory Bowel Diseases.

Authors:  Bharati Kochar; Christopher F Martin; Michael D Kappelman; Brennan M Spiegel; Wenli Chen; Robert S Sandler; Millie D Long
Journal:  Am J Gastroenterol       Date:  2017-08-29       Impact factor: 10.864

9.  Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease.

Authors:  Eliseo Papa; Michael Docktor; Christopher Smillie; Sarah Weber; Sarah P Preheim; Dirk Gevers; Georgia Giannoukos; Dawn Ciulla; Diana Tabbaa; Jay Ingram; David B Schauer; Doyle V Ward; Joshua R Korzenik; Ramnik J Xavier; Athos Bousvaros; Eric J Alm
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

10.  Inflammatory bowel disease in African American children compared with other racial/ethnic groups in a multicenter registry.

Authors:  Jolanda M White; Siobhán O'Connor; Harland S Winter; Melvin B Heyman; Barbara S Kirschner; George D Ferry; Stanley A Cohen; Robert N Baldassano; Terry Smith; Traci Clemons; Benjamin D Gold
Journal:  Clin Gastroenterol Hepatol       Date:  2008-10-09       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.